Thomas Cook (India) has strengthened its presence in the National Capital Region with the inauguration of a new franchise ‘Gold Circle Partner’ outlet at East Centre Mall, Laxmi Nagar in New Delhi. This expansion augments the company’s distribution and reach in NCR to 16 consumer access centres: 6 owned branches, 10 Gold Circle Partner (franchise) outlets.Thomas Cook (India) is the leading integrated travel and travel related financial services company in the country offering a broad spectrum of services that include Foreign Exchange, Corporate Travel, MICE, Leisure Travel, Insurance, Visa & Passport services and E-Business.
Bharti Airtel has added 31.48 lakh users in October 2017. Following this, the company’s total customer base has increased to 28.51 crore with market share of 29.90%.Bharti Airtel is a leading integrated telecommunications company with operations across Asia and Africa. The company ranks amongst the top 3 mobile service providers globally in terms of subscribers.
Idea Cellular has added 713,408 new mobile subscribers in October, 2017. Following this, the company’s total customer base has increased to 19.08 crore with markets share of 20.01%.Idea Cellular is an AV Birla group company and provides Global System for Mobile communications (GSM)-based wireless service at the pan-India level.
Ajanta Pharma has launched Clonidine Hydrochloride Extended Release Tablets in the US Market through its wholly owned subsidiary Ajanta Pharma USA. It is a bioequivalent generic version of Kapvay Tablets and company has launched the product in 0.1mg dosage.Clonidine Hydrochloride Extended Release Tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 39 Abbreviated New Drug Applications (ANDAs) of which it has 22 final ANDA approvals, 2 tentative approvals, and 15 ANDAs under review with USFDA. Till date, it has launched 16 products in the US market.Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.